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The mammalian target of rapamycin (mTOR) was recently
identified in two structurally distinct multiprotein complexes:
mTORC1 and mTORC2. Previously, we found that Rictor/
mTORC2 protects against cisplatin-induced acute kidney
injury, but the role and mechanisms for Rictor/mTORC2 in
TGFβ1-induced fibroblast activation and kidney fibrosis
remains unknown. To study this, we initially treated NRK-49F
cells with TGFβ1 and found that TGFβ1 could activate Rictor/
mTORC2 signaling in cultured cells. Blocking Rictor/mTORC2
signaling with Rictor or Akt1 small interfering RNAs markedly
inhibited TGFβ1-induced fibronection and α-smooth muscle
actin expression. Ensuing western blotting or immunostaining
results showed that Rictor/mTORC2 signaling was activated in
kidney interstitial myofibroblasts from mice with unilateral
ureteral obstruction. Next, a mouse model with fibroblast-
specific deletion of Rictor was generated. These knockout
mice were normal at birth and had no obvious kidney
dysfunction or kidney morphological abnormality within
2 months of birth. Compared with control littermates, the
kidneys of Rictor knockout mice developed less interstitial
extracellular matrix deposition and inflammatory cell
infiltration at 1 or 2 weeks after ureteral obstruction. Thus our
study suggests that Rictor/mTORC2 signaling activation
mediates TGFβ1-induced fibroblast activation and contributes
to the development of kidney fibrosis. This may provide a
therapeutic target for chronic kidney diseases.
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Kidney interstitial fibrosis is one of the major pathological
features for chronic kidney diseases. Fibroblasts in the kidneys
have an essential role in maintaining the homeostasis of
interstitial matrix and adjacent tissue under physiological
condition. Although all cell types in the kidneys are involved
in the pathogenesis of kidney fibrosis, fibroblasts which
acquire the phenotype of myofibroblast and generate a large
amount of interstitial matrix upon activation are the principal
matrix-producing cells.1–4
The ‘target of rapamycin’ (TOR) is a serine/threonine
kinase that controls cell metabolism, growth, proliferation,
survival, and aging. Mammalian TOR kinase (mTOR) exists
in two structurally and functionally distinct protein com-
plexes, named mTOR complex 1 (mTORC1) and mTOR
complex 2 (mTORC2).5–7 A number of studies demonstrated
that mTORC1 signaling has an important role in several
forms of kidney disease.8–12 Our and the other’s studies report
that mTORC1 signaling is linked to the fibrogenic process
through promoting fibroblast activation.13,14 MTORC2 con-
sists of mTOR kinase, Rictor, mSIN1, Protor, mLST8, and
DEPTOR. Among them, Rictor, acting as a scaffold protein,
facilitates both the assembly of mTORC2 and the interaction
of mTORC2 with its substrates and regulators. Ablation of
Rictor diminishes mTORC2 signaling. MTORC2 may control
cell survival, actin cytoskeleton organization, and other
processes through phosphorylating several members of the
AGC kinase family, including Akt, SGK1, and protein kinase
C (PKC).6,7,15–19 Our previous study reports that Rictor/
mTORC2 signaling is crucial for protecting against cisplatin-
induced tubular epithelial cell death.20 MTORC2 pathway is
reported to be an essential downstream branch of TGFβ1
signaling and represents a responsive target to inhibit
cancer cell epithelial-to-mesenchymal transition.21 Blocking
mTORC2 signaling with MLN0128, an active site dual mTOR
inhibitor, could largely inhibit TGFβ1-induced lung fibroblast
activation and lung fibrosis.22 Together, it is highly possible
that Rictor/mTORC2 signaling have an important role in
mediating TGFβ1-induced renal fibroblast activation and
kidney fibrosis.
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In this study, we found that TGFβ1 could induce Rictor/
mTORC2 signaling activation in NRK-49F cells, and blocking
this signaling inhibited TGFβ1-induced fibroblast activation.
Mice with fibroblast-specific deletion of Rictor are phenotypic
normal, and less kidney fibrosis could be detected in the
knockout kidneys compared with those in the control
littermates after unilateral ureter obstruction (UUO).
RESULTS
TGFβ1 induces Rictor/mTORC2 signaling activation in
NRK-49F cells
NRK-49F cells, a rat kidney interstitial fibroblast cell line,
were treated with TGFβ1 (2 ng/ml) for different time duration
and dosage as indicated. As shown in Figure 1a and b,
Rictor expression was induced at as early as 15 min, reached
peak from 0.5 to 6 h and declined at 12 h after treatment.
Following the induction of Rictor, the abundance of p-Akt
(Ser473) began to increase at 3 h and reached peak from 6 to
24 h. Phosphorylated SGK1 was induced at a similar pattern
with p-Akt (Ser473). The p-Akt (Thr308) abundance was
continuously increased within 48 h after TGFβ1 treatment.
NRK-49F cells were also treated with TGFβ1 at different dosage
as indicated and harvested at 6 h after treatment. The western
blotting analyses revealed that TGFβ1 could upregulate Rictor,
p-Akt (Ser473), and p-Akt (Thr308) expression in a dose-
dependent manner (Figure 1c). Immunofluorescent staining
results showed that Rictor protein was increased in NRK-49F
cells and mainly located in the cytosol at 6 h after TGFβ1
treatment (Figure 1d). TGFβ1 could induce the expression of
Rictor mRNA at 0.5 and 1 h after treatment (Figure 1e).
Together, it is concluded that TGFβ1 may activate mTORC2
signaling in kidney fibroblasts.
Rictor/mTORC2 signaling activation mediates TGFβ1-induced
fibroblast activation
The role for Rictor/mTORC2 signaling in TGFβ1-induced
fibroblast activation was then investigated. NRK-49F cells
were transfected with scramble or Rictor small interfering
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Figure 1 | Transforming growth factor β1 (TGFβ1) induces Rictor/mammalian target of rapamycin complex 2 (mTORC2) signaling
activation in NRK-49F cells. NRK-49F cells were treated with TGFβ1 for different time or dosage as indicated. (a–c) Western blotting analyses
showing the induction and activation of Rictor/mTORC2 signaling after TGFβ1 treatment in a time- (a, b) and dose-dependent (c) manner.
Cell lysates were immunoblotted with Abs against Rictor, p-Akt (Ser473), p-Akt (Thr308), Akt, p-SGK1, and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), respectively. (b) Graphic presentation showing the changes for the Rictor and p-Akt (Ser473) normalized to GAPDH
and Akt, respectively. (d) Representative micrographs of immunofluorescent staining showing the induction of Rictor in NRK-49F cells after
TGFβ1 treatment. Cells were co-stained with DAPI (4,6-diamidino-2-phenylindole) to visualize the nuclei. Scale bar = 10 μm. (e) The graph
showing the results of Rictor mRNA abundance by the real-time PCR analysis. *Po0.05 compared with control (n= 4).
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RNA (siRNA). As shown in Figure 2a, at 24 h after
transfection, Rictor protein expression was downregulated
about 55% in cells transfected with Rictor siRNA compared
with those transfected with scramble siRNA. To investigate
the role for Rictor on TGFβ1-induced Akt phosphorylation,
NRK-49F cells transfected with scramble or Rictor siRNA
were treated with TGFβ1 for 3 and 6 h. As shown in
Figure 2b, TGFβ1 treatment could largely increase p-Akt
(Ser473), p-Akt (Thr308), and p-S6 abundance in cells
transfected with scramble siRNA, whereas in Rictor siRNA-
transfected cells, the abundance for p-Akt (Ser473) but not
p-Akt (Thr308) or p-S6 was largely diminished, suggesting
that the induction of p-Akt (Ser473) was dependent on Rictor
in NRK-49F cells. To further determine the induction of
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Figure 2 |Knocking down Rictor expression diminishes transforming growth factor β1 (TGFβ1)-induced Akt phosphorylation as well as
fibroblast activation. NRK-49F cells were pretreated with scramble or Rictor small interfering RNA (siRNA) for 24 h, followed by TGFβ1
treatment for different time as indicated. (a) Western blotting analyses revealing the downregulation of Rictor protein in NRK-49F cells at 24 h
after Rictor siRNA transfection. The relative abundance of Rictor protein was listed under the image. (b) Western blotting analyses showing that
knocking down Rictor blocked TGFβ1-induced Akt phosphorylation at Ser473. The abundance of Akt phosphorylation at Thr308 as well as p-S6
was not changed in the cells transfected with Rictor siRNA. Cell lysates were immunoblotted with Abs against p-Akt (ser473), p-Akt (Thr308), Akt,
p-S6, S6, and Actin, respectively. (c) Western blotting analyses showing that knocking down Rictor inhibited fibronectin (FN) and α-smooth
muscle actin (α-SMA) expression at 48 h after TGFβ1 treatment. (d) Graphic presentation for FN and α-SMA protein expression in NRK-49F cells.
*Po0.05 compared with controls (n=3); #Po0.05 compared with TGFβ1-treated cells (n= 3). (e) Representative micrographs showing the
immunostaining for FN and α-SMA after various treatments as indicated. NRK-49F cells were transfected with scramble or Rictor siRNA and then
incubated with TGFβ1 (2 ng/ml) for 48 h. Cells were co-stained with DAPI (4,6-diamidino-2-phenylindole) to visualize the nuclei. Scale
bar = 10 μm. (f) The graph showing the results of α-SMA and FN mRNA abundance after TGFβ1 treatment. *Po0.05 compared with vehicle
control (n= 4), #Po0.05 compared with those cells treated with scramble siRNA transfection and TGFβ1 (n=4).
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Rictor on TGFβ1-induced fibroblast activation, NRK-49F
cells transfected with different sets of the siRNA were treated
with TGFβ1 (2 ng/ml) for 48 h. As shown in Figure 2c and d,
TGFβ1 could remarkably induce fibronectin (FN) and
α-smooth muscle actin (α-SMA) expression in scramble
siRNA-transfected cells, while Rictor siRNA transfection could
markedly decrease their expression. Immunofluorescent
staining further confirmed western blotting results for FN
and α-SMA in NRK-49F cells (Figure 2e). We also detected
the mRNA abundance of FN and α-SMA in NRK-49F cells by
real-time PCR assay. The induction of FN and α-SMA mRNA
expression after TGFβ1 treatment was decreased in Rictor
siRNA-transfected cells (Figure 2f). Knocking down Rictor
could not affect Smad3 phosphorylation induced by TGFβ1
treatment, suggesting that the profibrotic role of Rictor
in fibroblast is independent of Smad3 phosphorylation
(Supplementary Figure S1).
Akt1 and Akt2 but not Akt3 mRNA are expressed in the
kidneys,23 and mTORC2 is able to regulate the activity of both
Akt1 and Akt2.24,25 To decipher the role for Akt in TGFβ1-
Induced fibroblast activation, NRK-49F cells were transfected
with scramble, Akt1 or Akt2 siRNA. As shown in Figure 3a
and d, Akt1 or Akt2 siRNA transfection could markedly
downregulate Akt1 or Akt2 protein expression, respectively,
compared with those transfected with scramble siRNA.
NRK-49F cells were transfected with different sets of siRNA
for 24 h, followed by TGFβ1 treatment for 48 h. Similar to
Rictor siRNA transfection, Akt1 siRNA transfection could
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Figure 3 |Knocking down Akt diminishes transforming growth factor β1 (TGFβ1)-induced fibroblast activation. NRK-49F cells were
pretreated with scramble, Akt1, or Akt2 small interfering RNA (siRNA) for 24 h, followed by TGFβ1 (2 ng/ml) treatment. (a, d) Western blotting
analyses demonstrating the downregulation of Akt1 (a) or Akt2 (d) after siRNA transfection, respectively. (b) Western blotting analyses showing
that knocking down Akt1 inhibited TGFβ1-induced fibronectin (FN) and α-smooth muscle actin (α-SMA) expression in NRK-49F cells. Cell lysates
were immunoblotted with Abs against FN, α-SMA, and Actin, respectively. (c) Graphic presentation for FN and α-SMA protein expression in
NRK-49F cells administered with scramble or Akt1 siRNA and followed by TGFβ1 treatment. *Po0.05 compared with controls (n=3); #Po0.05
compared with TGFβ1-treated cells (n= 3). (e) Western blotting analyses showing that knocking down Akt2 could inhibit TGFβ1-induced α-SMA
expression at 48 h after treatment. (f) Graphic presentation for FN and α-SMA protein abundance. *Po0.05 compared with controls (n= 3);
#Po0.05 compared with TGFβ1-treated cells (n= 3). (g) Representative micrographs showing the immunostaining for FN and α-SMA.
Cells were co-stained with DAPI (4,6-diamidino-2-phenylindole) to visualize the nuclei. Scale bar = 10 μm.
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markedly downregulate TGFβ1-induced FN and α-SMA
expression (Figure 3b and c). However, Akt2 siRNA
transfection could only significantly decrease α-SMA expres-
sion induced by TGFβ1 treatment (Figure 3e and f).
Immunofluorescent staining further confirmed the results of
western blotting assay (Figure 3g). The mRNA abundance for
α-SMA and FN in the cells transfected with Akt1 siRNA was
also significantly downregulated compared with those trans-
fected with scramble siRNA at 24 h after TGFβ1 treatment
(Supplementary Figure S2). Thus it is clear that Rictor/
mTORC2/Akt signaling activation has an important role in
mediating TGFβ1-induced fibroblast activation.
Rictor/mTORC2 signaling is activated in myofibroblasts from
fibrotic kidneys
The activation of Rictor/mTORC2 signaling in myofibroblasts
was further investigated in the fibrotic kidneys from mice
with UUO nephropathy. Similar to the previous report,26 the
UUO kidneys developed severe interstitial fibrosis at 7 and
14 days after operation (data not shown). Western blotting
analysis was employed to identify the activation of mTORC2
signaling. As shown in Figure 4a, pronounced induction of
Rictor protein and p-Akt (ser473) was detected in the fibrotic
kidneys at 7 and 14 days after UUO. To identify the cell types
in which Rictor was induced, an immunohistochemical
staining for Rictor was deployed. As shown in Figure 4c,
the staining for Rictor protein was weak in both tubular cells
and interstitial cells from the sham kidneys. However, in
UUO kidneys, the staining for Rictor was markedly enhanced
in both tubular cells and interstitial cells. The kidney sections
were then co-stained with antibodies against α-SMA and
Rictor to further identify the expression of Rictor in
myofibroblasts in the UUO kidneys. The results showed that
very weak expression for α-SMA or Rictor was detected in the
interstitial cells from the sham kidneys, while in the UUO
kidneys the induction of Rictor in α-SMA-positive cells could
be detected, suggesting the induction of Rictor in myofibro-
blasts in the UUO kidneys. Thus these results suggest that
Rictor/mTORC2 signaling is activated in the myofibroblasts
from the fibrotic kidneys with UUO nephropathy.
Generation of mice with fibroblast-specific deletion of Rictor
To further explore the role of Rictor/mTORC2 signaling in
fibroblast activation and kidney fibrosis in vivo, we generated
a mouse model with fibroblast-specific deletion of Rictor gene
by utilizing the Cre-LoxP system. Figure 5a shows the
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Figure 4 |Activation of Rictor/mammalian target of rapamycin complex 2 (mTORC2) signaling in the interstitial myofibroblasts from
fibrotic kidneys. (a) Western blotting analyses showing the induction of Rictor, p-Akt (Ser473), p-Akt (Thr308), and phosphorylated protein
kinase Cα (p-PKCα) in the kidneys with unilateral ureter obstruction (UUO) nephropathy compared with sham control. Kidneys were collected at
day 7 and 14 after UUO. Kidney tissue lysates were immunoblotted with Abs against Rictor, p-Akt (Ser473), p-Akt (Thr308), Akt, p-PKCα, PKCα,
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), respectively. Numbers (1–3) indicate each individual animal in a given group.
(b) Graphic presentation showing the relative abundance for Rictor, p-Akt (Ser473), p-Akt (Thr308), and p-PKCα normalized to Akt and
PKCα, respectively. *Po0.05 compared with sham controls (n= 3). (c) Representative micrographs showing the immunostaining results
for Rictor in the kidneys at day 14 after UUO. Kidney sections from the sham and UUO mice were immunostained with antibody against
Rictor. Black arrows indicate interstitial cells. Asterisk indicates the tubule. Scale bar = 20 μm. (d) Representative micrographs showing
immunostaining results for Rictor and α-SMA in the kidneys at day 14 after UUO. Kidney sections from the sham and UUO mice were co-stained
with Abs against Rictor and α-SMA. Slides were counterstained with DAPI (4,6-diamidino-2-phenylindole) to visualize cell nuclei. White arrows
indicate the interstitial cells. Scale bar = 20 μm.
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Figure 5 |Generating the mice with fibroblast-specific ablation of the Rictor. (a) Diagram illustrates the strategy for generating mice with
fibroblast-specific deletion of Rictor. (b) Genotyping the mice by PCR analysis of genomic DNA. (c) Western blotting analyses showing Rictor
protein abundance in the kidney lysates from Fibro-Rictor− /− mice and their control littermates at day 14 after unilateral ureter obstruction
(UUO). Kidney lysates were immunoblotted with Abs against Rictor and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), respectively.
(d) Representative micrographs showing immunohistochemical staining results for Rictor in the kidneys at day 14 after UUO. The kidney tissue
was stained with Ab against Rictor. Scale bar = 20 μm. (e–i) There was no difference as to body weight (e), kidney/body weight (f), blood urea
nitrogen (BUN) (g), serum creatinine (h), and urinary albumin level (i) between control littermates and Fibro-Rictor− /−mice within 2 months
after birth (n= 4-6). (j) Western blotting analyses showing the p-Akt (Ser473) abundance in the kidney lysates from Fibro-Rictor − /− mice and
their control littermates at day 14 after UUO. Kidney tissue lysates were immunoblotted with Abs against p-Akt (Ser473), p-Akt (Thr308), Akt,
p-Smad3, and GAPDH, respectively. (k) Graphic presentation showing the relative p-Akt (Ser473), p-Akt (Thr308), and p-Smad3 abundance
normalized to Akt or GAPDH, respectively. *Po0.05 compared with sham controls (n=3–4); #Po0.05 compared with control littermates (n= 3–
4). (l) Representative micrographs showing the immunostaining results for Fsp1 and p-Akt (Ser473) in the kidneys at day 14 after UUO. The
kidney tissue was stained with Abs against Fsp1 and p-Akt (Ser473). Arrows indicate Fsp1 and p-Akt (Ser473)-positive cells. Asterisks indicate
Fsp1-positive but p-Akt (Ser473)-negative cells in the knockout kidneys. Scale bar = 20 μm.
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breeding strategy for generating the knockout mice. Mice
with fibroblast-specific ablation of Rictor were named as
Fibro-Rictor− /− (Figure 5b, lane 1), whereas age and
gender matched Rictor-floxed littermates were considered
as controls (Fibro-Rictor+/+, Figure 5b, lane 3). Western
blotting analysis and immunostaining were used to examine
the expression of Rictor protein in the kidneys. Rictor protein
abundance was markedly reduced in the UUO kidneys from
Fibro-Rictor− /− mice compared with those from control
littermates (Figure 5c and d). All mice were born normal with
expected Mendelian frequency. No significant difference was
observed in body weight, kidney/body weight ratio, urinary
albumin excretion, blood urea nitrogen or serum creatinine
level between the knockouts and control littermates within
2 months after birth, respectively (Figure 5e–i). In short,
Fibro-Rictor− /− mice were phenotypic normal under
physiological condition.
The mice were subjected to UUO and the Akt phosphory-
lation was analyzed by western blotting assay. As shown in
Figure 5j and k, in the UUO kidneys from control littermates,
Akt kinase activation exhibited as Akt phosphorylation
(Ser473 and Thr308) were largely induced at day 14, whereas
in the Fibro-Rictor− /− kidneys p-Akt (Ser473) abundance
was much less. In addition, p-Akt (Thr308) was also signi-
ficantly diminished in the knockout kidneys after UUO.
Phosphorylated Smad3 was upregulated in the UUO kidneys
from control littermates and was slightly decreased in the
knockout kidneys. Double staining of Abs against Fsp1 and
p-Akt (Ser473) showed that phosphorylated Akt at Ser473
could be detected in Fsp1-positive cells in the kidneys with
UUO nephropathy, whereas p-Akt (Ser473) was negative
in Fsp1-positive cells in the knockout kidneys after UUO
(Figure 5l). These results suggest that deletion of Rictor in
fibroblasts diminishes Akt phosphorylation at Ser473 in the
fibroblasts from the UUO kidneys.
Specific deletion of Rictor in fibroblasts ameliorates kidney
interstitial fibrosis in mice with UUO nephropathy
The above data demonstrated that deletion of Rictor in
fibroblasts diminished Akt kinase phosphorylation in the
kidneys with UUO nephropathy. Kidney sections from
different groups were stained with periodic acid–Schiff,
Masson, or Sirius red. In the sham groups, the kidney
morphology was comparable between the knockouts and
controls. In the kidneys with UUO nephropathy from control
littermates, remarkably tubular atrophy and interstitial
extracellular matrix deposition could be found, whereas in
the knockout kidneys tubular damage as well as extracellular
matrix deposition were largely alleviated (Figure 6a). As
shown in Figure 6b, the fibrotic area was largely increased in
the control littermates with UUO nephropathy, whereas
specific deletion of Rictor in fibroblast could markedly
ameliorate kidney fibrosis. The total collagen content within
the kidneys was significantly increased at 1 or 2 weeks after
UUO from control littermates, and in the knockout kidneys,
total collagen content was diminished (Figure 6c).
Fibronectin, α-SMA, and type I collagen expression in the
kidneys were also examined by western blotting assay and
immunostaining. As shown in Figure 7a and b, FN, α-SMA,
and type I collagen protein abundance were remarkably
increased after UUO in control littermates, and they were
significantly decreased in the knockout kidneys compared
with those in the control littermates. immunostaining for FN,
α-SMA, and type I collagen further confirmed the results of
western blotting assay (Figure 7c). Taken together, these
results demonstrate that specific deletion of Rictor in fibro-
blasts ameliorates fibroblast activation and kidney fibrosis
after UUO operation.
Kidney interstitial cell apoptosis is decreased in the
knockouts with UUO nephropathy
Our previous study demonstrated that Rictor/mTORC2
signaling has a critical role in protecting against tubular cell
death induced by cisplatin treatment.20 To investigate cell
survival status in the UUO kidneys from the knockouts,
TUNEL (terminal deoxynucleotidyl transferase-mediated
dUTP-fluorescein nick end labeling) staining was employed.
As shown in Figure 8a and b, in the sham groups, few
TUNEL-positive tubular or interstitial cells could be detected.
In the UUO kidneys from control littermates, at day 14 after
surgery the number for TUNEL-positive tubular or interstitial
cells was significantly increased, while in the UUO kidneys
from the knockouts both tubular cell and interstitial cell
apoptosis was significantly ameliorated compared with those
in the control littermates. These results suggest that fibroblast
apoptosis in the knockout kidneys is not exacerbated under
physiological condition or after UUO compared with those in
control littermates.
Ablation of Rictor in the fibroblasts attenuates macrophage
infiltration in kidneys with UUO nephropathy
Kidney interstitial macrophage infiltration is one of the most
important features of chronic kidney diseases. To evaluate the
macrophage infiltration in the kidneys, immunostaining for
F4/80 was employed, and F4/80+ cells were counted in at least
five randomly selected fields (×400) for each sample. As
shown in Figure 9a and b, few F4/80-positive cells were
detected in the sham groups. The number of F4/80-positive
cell was significantly increased in the kidneys with UUO
nephropathy from control littermates, while in the knockout
kidneys macrophage infiltration was much less. We per-
formed co-immunostaining of anti-Fsp1 with anti-α-SMA or
with anti-F4/80 on the kidney tissues with UUO nephropathy.
Immunofluorescent staining results showed that 73.7% of the
Fsp1-positive cells expressed α-SMA; about 16.4% of the
Fsp1-postive cells were co-stained with F4/80; and only 5.8%
of the F4/80-positive cells were Fsp1 positive (Figure 9c).
DISCUSSION
Fibroblasts are regarded as the principal cells that generate a
large amount of matrix components that accumulate within
the interstitial space upon activation.2,27–36 It has been
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reported that mTORC1 signaling mediates the fibrogenic
process through promoting fibroblast activation and kidney
interstitial fibrosis.8,13,37 Here we demonstrated that Rictor/
mTORC2 signaling activation contributes to TGFβ1-
promoted fibroblast activation independent of mTORC1
signaling.
In cultured NRK-49F cells, TGFβ1 treatment could induce
both mTORC1 and mTORC2 signaling activation at a similar
pattern and blocking either one of them could partially
interfere with TGFβ1-induced fibroblast activation. It may be
concluded that the activation of both signaling are required
for the full activation of fibroblast after TGFβ1 treatment. In
in vivo studies, we found that phosphorylated Smad3 was
slightly decreased in the knockout kidneys after UUO
operation compared with those in the control littermates,
which suggest that long-term ablation of mTORC2 may
reduce the activity of TGFβ1 itself. However, how does
TGFβ1 induce these signaling activation in kidney fibroblasts
is not clear?
The crosstalk between two complexes is complicated and
seems on a cellular context–dependent manner. MTORC1
may impair the activation of mTORC2 by phosphorylating
insulin receptor substrate-1, Grb10, or Sin1.38–40 Whereas
Humphrey et al.41 found that phosphorylation of Thr 86 in
Sin1 actually augments mTORC2 activity. MTORC2 may
stimulate mTORC1 signaling activation through phosphory-
lated Akt at Ser473, an activator of mTORC1 through
phosphorylation of TSC2. However, in this study, we found
that knocking down Rictor expression could not affect
TGFβ1-induced S6 phosphorylation, suggesting that the
profibrotic role of mTORC2 is independent of mTORC1
signaling in kidney fibroblast (Figure 2b). Because of the
overall complexity of the context-dependent regulation and
function of the mTOR pathway, and most of the results are
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not obtained from kidney fibroblast, further work is needed
to elucidate the interaction between mTORC1 and mTORC2
in kidney fibroblast activation and kidney fibrosis.
Akt kinase controls many fundamental cellular processes,
such as cell proliferation and survival.20,24,42,43 Inhibition of
phosphatidylinositol 3′-kinase/Akt signaling may ameliorate
UUO nephropathy in mice.44–46 In the kidneys, Akt1 and
Akt2 but not Akt3 can be detected.23 MTORC2 may regulate
the activity of both Akt1 and Akt2.24,25,47 In this study,
downregulating Akt1 could inhibit TGFβ1-induced FN and α-
SMA expression, while downregulating Akt2 could only
diminish TGFβ1-induced α-SMA expression. Except for
Akt, SGK1 phosphorylation was also increased after TGFβ1
treatment. Considering the critical role of SGK1 activation in
promoting kidney fibrosis,48 SGK1 phosphorylation may also
contribute to TGFβ1-induced kidney fibroblast activation. It
has been reported that Rictor/mTORC2 signaling is impor-
tant for the regulation of energy and glucose metabolism in
many cell types.17 Whether Rictor/mTORC2 signaling
mediating TGFβ1-promoted fibroblast activation is through
regulating cellular energy and glucose metabolism needs
further investigation.
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In this study, no obvious phenotypic change could be
found within 2 months after birth in mice with fibroblast-
specific deletion of Rictor gene, indicating that Rictor/
mTORC2 in fibroblast is dispensable under physiological
condition in vivo. Our previous studies report that Rictor/
mTORC2 signaling in tubular cells is protective against
cisplatin-induced cell apoptosis and acute kidney injury.
However, in this study, both interstitial cell and tubular cell
apoptosis were largely decreased in the knockout kidneys after
UUO compared with their control littermates. Less kidney
injury may account for the less apoptotic tubular or
interstitial cells in the knockout kidneys. It is of note here
that a paracrine mediator such as miR-34a derived from
fibroblast in fibrotic kidneys may induce tubular cell
apoptosis.49 However, whether mTORC2 mediates TGFβ1-
induced miR-34a production in fibroblast is not clear.
Interstitial accumulation of macrophages is strongly
associated with the progression of renal injury in UUO
model.4,50,51 Fibro-Rictor− /− mice exhibited less macro-
phage infiltration compared with those in control littermates
after UUO. As 5.8% of the macrophages express Fsp1 in the
fibrotic kidneys, the function of this portion of the macro-
phages may be impaired in the knockouts. Less macrophage
infiltration in the knockout kidneys may account for three
reasons: the first one is that less kidney injury in the
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knockouts may lead to decreased macrophage infiltration; the
second one is that Rictor/mTORC2 signaling activation in
fibroblasts may directly stimulate interstitial inflammation
under diseased condition; and the third one is that the
deletion of Rictor in some macrophages may impair their
function (Figure 9c).
In conclusion, this study demonstrated that Rictor/
mTORC2 signaling has an important role in mediating
TGFβ1-induced fibroblast activation and kidney fibrosis.
Targeting this signaling pathway may provide a new strategy
for inhibiting the progression of chronic kidney diseases.
MATERIALS AND METHODS
Mice and animal models
Homozygous Rictor floxed mice (C57BL/6J background) were kindly
provided by Dr Magnuson from the University of Vanderbilt.19 The
S100a4-Cre transgenic mice expressing Cre recombinase under the
control of the mouse S100a4 promoter were ordered from Jackson
Laboratory (012641, C57BL/6J background, The Jackson Laboratory,
Bar Harbor, ME). All animals were maintained in the specific
pathogen-free Laboratory Animal Center of Nanjing Medical
University according to the guidelines of the Institutional Animal
Care and Use Committee at Nanjing Medical University, Nanjing,
China. By mating Rictor floxed mice with S100a4-Cre transgenic
mice, mice that were heterozygous for the Rictor-floxed allele were
generated (genotype: Rictor fl/wt, Cre+/− ). These mice were
crossbred with homozygous Rictor floxed mice (genotype: Rictor
fl/fl) to generate offspring with specific deletion of Rictor in the
fibroblasts (Fibro-Rictor− /− , genotype: Rictor fl/fl, Cre+/− ). The
breeding protocol also generated heterozygous littermates (genotype:
Rictor fl/wt, Cre+/− ) and the other groups of mice (Rictor fl/fl,
Cre− /− ; Rictor fl/wt). The same gender mice genotyping Rictor fl/fl,
Cre− /− from the same litters with the knockouts were considered
as control littermates. Genotyping was performed by PCR assay
using DNA extracted from the mouse tail. The primers used for
genotyping were as follows: Cre transgene, sense: 5′-TTGCCTGCA
TTACCGGTCGATGC-3′ and anti-sense: 5′-TTGCACGTTCACC
GGCATCAACG-3′; and Rictor genotyping, sense:5′-GACACTGGA
TTACAGTGGCTTG-3′ and anti-sense: 5′-GCTGGGCCATCT
GAATAACTTC-3′.
Male CD1 mice weighing ~ 18–22 g were acquired from the
specific pathogen-free Laboratory Animal Center of Nanjing Medical
University and maintained according to the guidelines of the
Institutional Animal Care and Use Committee at Nanjing Medical
University. UUO was performed as previously reported.2 The UUO
kidneys were harvested at days 7 and 14 after surgery. One portion of
the kidney was fixed in 10% phosphate-buffered formalin, followed
by paraffin embedding for histological and immunohistochemical
staining. Another portion was immediately frozen in Tissue-Tek
optimum cutting temperature compound (Sakura Finetek, Torrance,
CA) for cryosection. The remaining kidney tissue was snap-frozen in
liquid nitrogen and stored at − 80 °C for extraction of RNA and protein.
Cell culture and treatment
Rat kidney interstitial fibroblasts (NRK-49F) cells were obtained
from American Type Culture Collection (Manassas, VA). Cells were
cultured in Dulbecco’s modified Eagle’s medium/F12 medium
supplemented with 10% fetal bovine serum (Invitrogen, Grand
Island, NY). The cells were seeded on six-well culture plates to
60–70% confluence in complete medium containing 10% fetal
bovine serum for 16 h and then changed to serum-free medium after
washing twice with serum-free medium. Recombinant human
TGFβ1 (cat.: 100-B-010-CF, R&D Systems, Minneapolis, MN) was
added to the serum-free medium for various periods of time. Rictor
or Scramble siRNA (GenePharma, Shanghai, China) was transfected
into NRK-49F cells using Lipofectamine 2000 reagent (Invitrogen)
according to the manufacturer’s instruction.
Urinary albumin, serum creatinine, and blood urea nitrogen
assay
Urinary albumin concentration was measured by using a
mouse Albumin ELISA Quantification Kit (Bethyl Laboratories,
Montgomery, TX). Serum creatinine was measured with the
QuantiChrom Creatinine Assay Kit (cat.: DICT-500, Bioassay
Systems, Hayward, CA), and blood urea nitrogen was measured
with the QuantiChrom Urea Assay Kit (cat.: DIUR-500, Bioassay
Systems) according to the manufacturer’s instructions.
Histology and immunohistochemistry
Kidney samples were fixed in 10% neutral formalin and embedded in
paraffin. Three-μm thick sections were used for periodic acid–Schiff
and Masson staining. For immunohistochemical staining, paraffin-
embedded kidney sections were deparaffinized, hydrated, and
antigen-retrieved, and endogenous peroxidase activity was quenched
by 3% H2O2. Sections were then blocked with 10% normal donkey
serum, followed by incubation with anti-Rictor (cat.: A300-459A,
Bethyl Laboratories), or anti-type I collagen (cat.: AB765P, Millipore,
Billerica, MA) over night at 4 ºC. After incubation with secondary
antibody for 1 h, sections were incubated with ABC reagents for 1 h
at room temperature before being subjected to substrate 3-amino-9-
ethylcarbazole or 3,3′diaminobenzidine (Vector Laboratories,
Burlingame, CA). Slides were viewed with a Nikon Eclipse 80i
microscope equipped with a digital camera (DS-Ri1, Nikon,
Shanghai, China).
Immunofluorescent staining
Kidney cryosections at 3-μm thickness were fixed for 15min in 4%
paraformaldehyde, followed by permeabilization with 0.2% Triton
X-100 in phosphate-buffered saline (PBS) for 5min at room
temperature. After blocking with 2% donkey serum for 60min, the
slides were immunostained with anti-FN (cat.: F3648, Sigma-Aldrich,
St Louis, MO), anti-α-SMA (cat.: A5228, Sigma-Aldrich), anti-Rictor
(cat.: A300-459A, Bethyl Laboratories), anti-F4/80 (cat.: 14–4801,
eBioscience, San Diego, CA), anti-p-Akt (Ser473), or anti-Fsp1 (cat.:
A511401, Dako, Carpinteria, CA). Cells cultured on coverslips were
washed twice with cold 1×PBS and fixed with cold methanol/acetone
(1:1) for 10min at − 20 ºC. After three extensive washings with
1×PBS, the cells were treated with 0.1% TritonX-100 for 5 min and
blocked with 2% normal donkey serum in 1×PBS buffer for 40min
at room temperature and incubated with the Anti-Rictor, anti-FN, or
anti-α-SMA, followed by staining with fluorescein isothiocyanate or
tetramethylrhodamine-conjugated secondary antibody. Cells were also
stained with 4’,6-diamidino-2-phenylindole to visualize the nuclei.
Slides were viewed with a Nikon Eclipse 80i Epi-fluorescence micro-
scope equipped with a digital camera.
Quantitative determination of collagen in kidney tissue
The kidney tissue collagen was quantitated as previously reported.52
Briefly, 3-μm-thick sections of paraffin-embedded tissue were
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stained with Sirius red F3BA and Food Green FCF (Sigma-Aldrich)
overnight. After washing three times with 1 × PBS buffer, the dye was
eluted from tissue sections with 0.1 N sodium hydroxide methanol.
Absorbance at 540 and 605 nm were determined for Sirius red F3BA
and Food Green FCF-binding protein, respectively. This assay
provides a simple, relative measurement of the ratio of collagen to
total protein, which is expressed as micrograms per milligram of
total protein. As to the quantification of fibrotic area, kidney section
with Masson trichrome staining was used, and five randomly selected
fields for each animal under × 400 microscope were quantified. The
percentage of Masson-stained positive area was calculated using the
Image J software (NIH, Besthesda, MD). Five individual animals for
each group were used for matrix quantification.
Western blotting analysis
Cultural NRK-49F cells were lysed in 1 × sodium dodecyl sulfate
sample buffer. The kidneys were lysed with radio-
immunoprecipitation assay solution containing 1% NP40, 0.1%
sodium dodecyl sulfate, 100 mg/ml phenylmethanesulfonylfluoride,
1% protease inhibitor cocktail, and 1% phosphatase I and II
inhibitor cocktail (Sigma, St Louis, MO) on ice. The supernatants
were collected after centrifugation at 13,000 × g at 4 °C for 30 min.
Protein concentration was determined by bicinchoninic acid protein
assay (BCA Kit; Pierce Thermo-Scientific, Rockford, IL) according to
the manufacturer’s instructions. An equal amount of protein was
loaded into 10 or 12% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and transferred onto polyvinylidene difluoride
membranes. The primary antibodies were as follows: anti-Rictor
(cat.: ab70374, Abcam, Cambridge, MA) or anti-Rictor (cat.: A300-
459A, Bethyl Laboratories), anti-GAPDH (anti-glyceraldehyde 3-
phosphate dehydrogenase; cat.: FL-335, Santa Cruz Biotechnology,
Dallas, TX), anti-p-Akt (ser473) (cat.: 3868, Cell Signaling
Technology, Shanghai, China), anti-p-Akt (Thr308) (cat.: 2965, Cell
Signaling Technology), anti-Akt (cat.: 4691, Cell Signaling Technol-
ogy), anti-p-SGK1 (Ser422) (cat.: ab55281, Abcam), anti-p-Smad3
(Ser423/425) (cat.: ab52903, Abcam), anti-Akt1 (cat.: 2938, Cell
Signaling Technology), anti-Akt2 (cat.: 2964, Cell Signaling Tech-
nology, anti-p-PKCα (Thr638/641) (cat.: 9375, Cell Signaling
Technology), anti-PKCα (cat.: 2056, Cell Signaling Technology),
anti-FN (cat.: F3648, Sigma-Aldrich), anti-α-SMA (cat.: A5228,
Sigma-Aldrich), and anti-type I collagen (cat.: AB765P, Millipore).
Quantification was performed by measuring the intensity of the
signals with the aid of National Institutes of Health Image J software
package.
RNA isolation and real-time quantitative reverse
transcriptase–PCR
Total RNA was extracted using Trizol reagent (Invitrogen) according
to the manufacturer’s instructions. cDNA was synthesized with 1 μg
of total RNA, ReverTra Ace (Vazyme, Nanjing, China), and oligo
(dT) 12–18 primers. Gene expression was measured by real-time
PCR assay (Vazyme) and 7300 real-time PCR system (Applied
Biosystems, Foster City, CA). The relative amount of mRNA or gene
to internal control was calculated using the equation 2△CT, in which
△CT=CTgene −CTcontrol.
Statistical analysis
All data examined are presented as mean± s.e.m. Statistical analysis
of the data was performed using the SigmaStat software (Jandel
Scientific Software, San Rafael, CA). Comparison between groups
was made using one-way analysis of variance, followed by the
Student–Newman–Keuls test. Po0.05 was considered statistically
significant.
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